Trouble reading this e-mail? View it in your browser.

28 March 2014
Header image
Highlight of the week


UPDATE: Clinical Data Sharing – progress made against 2013 commitments
26 March 2014

(Brussels, Vienna – 26 March 2014): EFPIA today announced an update on industry progress made on the EFPIA-PhRMA Principles for Responsible Clinical Trials Data Sharing. [...] Read more

From our blog

From our blog

Aiming for a #HealthyEU – Countdown to European Elections – 8 weeks to go
27 March 2014 by Richard Torbett

Supporting Sustainable Healthcare Systems: Following the launch of its digital media campaign calling for an integrated life sciences strategy in the EU, EFPIA expands on the [...] Read more

From our blog

EMA’s Adaptive Licensing Pilot Project Signals an Exciting Step for Medicines Development
25 March 2014 by Magda Chlebus

The EMA’s announcement last week of an adaptive pathway pilot project with real medicines in development is a bold step in improving the way innovative [...] Read more

From our blog

World TB Day: Considering Collaborative Initiatives to Conquer TB
24 March 2014 by Magda Chlebus

In anticipation of World TB Day today, there have been a number of media reports covering the topic of Tuberculosis over the past weeks. It’s [...] Read more



Introducing the EFPIA Disclosure Code

EFPIA and its member associations and companies have adopted codes and guidelines to ensure that interactions between the pharmaceutical industry and healthcare professionals interactions meet the high standards of integrity that patients, governments and other stakeholders expect.

View video


From our blog

Strategic Research Agenda for Innovative Medicines Initiative 2
25 March 2014 (Publications)

The right prevention and treatment for the right patient at the right time - Strategic Research Agenda for Innovative Medicines Initiative 2  The SRA has been written to [...] Read more

What we are reading

What we are reading

Google Flu Trends is no longer good at predicting flu, scientists find
28 March 2014

Researchers warn of 'big data hubris' and the importance of updating analytical models, claiming Google has made inaccurate forecasts for 100 of 108 weeks.

Read more

What we are reading

Big Data Partnerships Tackle Drug Development Failures
28 March 2014

Drug development is a risky business, with an estimated 90 percent of compounds that enter clinical trials ultimately failing to reach the market.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail